Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability. [NA]
An update on a Parkinson disease trial evaluating brain stimulation to augment physical therapy for postural instability, with results poste…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control [NA]
A clinical trial is evaluating electrical stimulation of brain areas VOP and VIM to improve movement and muscle control in movement disorder…
-
FDA approval · 2025-11-10FDA Approved: ROPINIROLE — Original Application (Elite Laboratories, Inc.)
FDA approved Elite Laboratories, Inc.'s original application for a generic ropinirole product. The drug is indicated for Parkinson's disease…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease [NA]
A clinical trial at the University of North Carolina, Chapel Hill is recruiting to evaluate targeted motor learning to improve gait in peopl…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Bright Light Therapy for Non-motor Symptoms in Parkinson's Disease [NA]
ClinicalTrials.gov notes a study examining Bright Light Therapy for non-motor symptoms in Parkinson's disease. The trial is currently active…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease [Phase 1]
Phase 1 trial evaluating biomarker changes after sargramostim treatment in Parkinson's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
A completed Cleveland Clinic study explored using neural signatures and virtual reality to optimize deep brain stimulation programming for P…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease
The VA Office of Research and Development sponsors a study on the kinematic and neural dynamics of postural instability in Parkinson's disea…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease [Phase 2]
A Phase 2, 18-month study evaluating the efficacy, safety, tolerability, and pharmacokinetics of oral UCB0599 in early-stage Parkinson's dis…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Studies of Brain and Body Interaction
Rutgers University-sponsored clinical trial is recruiting to study brain-body interaction across autism spectrum disorders, ADHD and related…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL) [NA]
A clinical trial update on cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson disease (UDALL), curren…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
A completed clinical trial evaluating the mPDia clinical decision support system for neurodegenerative Parkinsonism using MRI images has pos…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease [Phase 1, Phase 2]
A Phase 1b/Phase 2 study of the NLRP3 inhibitor VENT-02 for Parkinson disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE) [Phase 1]
Phase 1 trial update evaluating the feasibility and safety of autologous unconditioned peripheral nerve tissue delivery to the substantia ni…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS [Phase 1]
This clinical-trial update indicates the continuation of a Phase 1 study evaluating implantation of peripheral nerve grafts into Parkinson's…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs [NA]
Clinical trial update examining how different exercise programs affect movement, fitness, and quality of life in people with Parkinson disea…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation [NA]
This completed clinical trial from North Carolina State University investigated suppressing tremor during grasp using ultrasound imaging and…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: rTMS Treatment of Dysphagia in Parkinson's Patients [NA]
A completed clinical trial from Ege University evaluated repetitive transcranial magnetic stimulation (rTMS) for treating dysphagia in patie…
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial [NA]
A clinical trial is investigating whether genetic factors and aerobic exercise can slow the progression of Parkinson disease, and is current…
-
CLINICAL_TRIALS other · 2025-10-23Clinical Trial Update: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 [Phase 2]
A Phase 2 clinical trial update describing BIIB122 for early-stage Parkinson disease; the study is listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease
A Massachusetts General Hospital-led clinical trial is studying gastrointestinal dysfunction and enteric neural pathology in Parkinson's dis…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
This clinical trial update notes ongoing recruitment in the United States for real-world use of continuous subcutaneous apomorphine infusion…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes [Phase 2]
Phase 2 trial evaluating Staccato Apomorphine (AZ-009) for Parkinson's disease patients experiencing OFF episodes has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback [NA]
A clinical trial evaluating bilateral closed-loop deep brain stimulation for freezing of gait in Parkinson disease has completed. The approa…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. [Phase 2]
A Phase 2 clinical trial evaluating the safety, tolerability, efficacy, and pharmacokinetics of FHL-301 in Parkinson's disease is planned bu…